ANDA 208478, held by Perrigo R And D. Atorvastatin Calcium.
As of Nov 16, 2026, ANDA 208478 (Atorvastatin Calcium), held by Perrigo R And D, was first approved by FDA on Jun 23, 2020, with 3 approved supplements and 0 published complete response letters.
| Date | Submission | Status | Documents |
|---|---|---|---|
| Jun 23, 2020 | Original application | Approved | None posted |
| Atorvastatin CalciumEQ 10MG BASE · tablet;oral | Atorvastatin Calcium | Discontinued |
| Atorvastatin CalciumEQ 20MG BASE · tablet;oral | Atorvastatin Calcium | Discontinued |
| Feb 7, 2025 | Supplement 5Labeling · Standard review | Approved | None posted |
| Feb 5, 2024 | Supplement 4Labeling · Standard review | Approved | None posted |
| Oct 25, 2022 | Supplement 2Labeling · Standard review | Approved | None posted |
| Jun 23, 2020 | Original application | Approved | None posted |
Approvals, supplements, products and documents come from FDA's Drugs@FDA data files, refreshed daily; Drugs@FDA lists approved applications only. Complete response letters are FDA's published letters. Drugs@FDA and FDA complete response letters